Evaluation and Treatment of Patients With Dermatologic Diseases
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This is a training, natural history of disease, and screening protocol for the evaluation, treatment and follow-up of patients with dermatologic diseases and systemic diseases with cutaneous manifestations. Patients enrolled in this protocol will be evaluated and treated according to generally available, standard procedures and therapeutic modalities. Samples of blood and skin will be studied by routine and specialized investigative methods to establish these patients' diagnosis, response to treatment, and/or disease progression.
| Condition |
|---|
|
Connective Tissue Disease Skin Disease |
| Study Type: | Observational |
| Official Title: | Evaluation and Treatment of Subjects With Dermatologic Diseases |
| Estimated Enrollment: | 500 |
| Study Start Date: | June 1996 |
Background
This is a training, natural history of disease, and screening protocol for the evaluation, treatment and follow-up of patients with dermatologic diseases and systemic diseases with cutaneous manifestations. This protocol was developed to allow subject enrollment for teaching purposes and to allow for second opinions regarding relatively complicated patients. The latter function promotes a critical link between the NCI, CCR Dermatology Branch and the local and national extramural medical communities.
Objective
Primary:
- To provide clinical material to fulfill the educational mission of the
Dermatology Branch.
- To learn about the natural history of selected dermatologic diseases.
Secondary:
- To screen patients for inclusion in other protocols.
- To assist in the diagnosis and/or management of patients with rare skin diseases and congenital or genetically linked skin conditions.
Eligibility
All subjects regardless of age, gender, or racial/ethnic group with dermatologic disease or systemic disease with cutaneous manifestations.
Design
Patients enrolled in this protocol will be evaluated and treated according to generally available, standard procedures and therapeutic modalities. Samples of blood and skin will be studied by routine and specialized investigative methods to establish these patients' diagnosis, response to treatment, and/or disease progression.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
- INCLUSION CRITERIA:
Patients of any age, of both genders, and all racial/ethnic groups with dermatologic diseases or systemic diseases with cutaneous manifestations.
Women of childbearing potential, or who are pregnant or lactating, will only undergo tests and procedures, and/or receive medications for which data exists proving minimal risk to the fetus and/or child. Only tests that are clinically indicated for diagnosis will be performed.
Patients must be referred by a physician.
EXCLUSION CRITERIA:
Patients with cognitive impairment.
Pregnancy or lactation, if this status precludes proposed diagnostic procedures or therapies because of known untoward effects on mother and/or child.
Contacts and Locations| Contact: Irene Ekwede | (301) 402-6225 | irene.ekwede@nih.gov |
| Contact: Mark C Udey, M.D. | (301) 496-2481 | udey@helix.nih.gov |
| United States, Maryland | |
| National Institutes of Health Clinical Center, 9000 Rockville Pike | Recruiting |
| Bethesda, Maryland, United States, 20892 | |
| Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office (888) NCI-1937 | |
| Contact: Irene Ekwede, B.S.N. (301) 402-6225 irene.ekwede@nih.gov | |
| Principal Investigator: | Mark C Udey, M.D. | National Cancer Institute (NCI) |
More Information
Additional Information:
Publications:
| ClinicalTrials.gov Identifier: | NCT00001506 History of Changes |
| Obsolete Identifiers: | NCT00019149 |
| Other Study ID Numbers: | 960102, 96-C-0102 |
| Study First Received: | November 3, 1999 |
| Last Updated: | March 29, 2013 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Institutes of Health Clinical Center (CC):
|
Training Protocol Natural History Consultation |
Standard Therapy Standard Tests Training |
Additional relevant MeSH terms:
|
Connective Tissue Diseases Skin Diseases |
ClinicalTrials.gov processed this record on May 21, 2013